PDF(1026 KB)
Efficacy of clonidine transdermal patch for treatment of Tourette's syndrome in children
KANG Hua, ZHANG Yue-Fang, JIAO Fu-Yong, GUO Xiang-Yang, GAO Xiao-Min
Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (07) : 537-539.
PDF(1026 KB)
PDF(1026 KB)
Efficacy of clonidine transdermal patch for treatment of Tourette's syndrome in children
OBJECTIVE: Children with Tourette's syndrome (TS) have a poor treatment compliance due to side effects and inconvenient administration of oral drugs. This study explored the efficacy and safety of clonidine transdermal patch for treating TS in children. METHODS: A total of 119 children with TS were randomly treated with the clonidine transdermal patch (n=65) or with oral haloperidol (n=54). The therapeutic efficacy was assessed based on the results of the Yale Global Tic Severity Scale (YGTSS) 4 weeks after treatment. RESULTS: The clonidine transdermal patch group showed a higher reduction in the overall tic symptom scores (61.5±7.5%) than that in the haloperidol group (41.0±6.3%; P<0.05). Clonidine transdermal patch treatment was effective in 53 patients (81.5%) and 36 patients (67.5%) showed effective to oral haloperidol (P>0.05). Mild side effects (decrease of blood pressure and dizziness) were observed in 1 patient in the clonidine transdermal patch group. Mild hypermyotonia, drowsiness or lassitude as side effects occurred in 6 patients in the haloperidol group. CONCLUSIONS: Clonidine transdermal patch is effective for the treatment of TS in children and its side effects are mild and rare.［Chin J Contemp Pediatr, 2009, 11 (7):537-539］
Clonidine transdermal patch / Haloperidol / Tourette’s syndrome / Child
［1］胡亚美，江载芳.诸福棠实用儿科学［M］.第7版.北京：人民卫生出版社，2005，1962-1964.
［2］中华医学会精神科学会.抽动障碍诊断标准，CCDM-Ⅱ-R［S］.南京：东方大学出版社,1995,118-120.
［3］钟佑泉,吴惧，谢晓丽，胡文广，周文智. 耶鲁抽动症整体严重度量表对抽动障碍患儿的临床评估［J］.中国实用儿科杂志，2006, 21（3）:214-216.
［4］Chang SW, McCracken JT, Piacentini JC. Neurocognitive correlates of child obsessive compulsive disorder and Tourette syndrome ［J］. J Clin Exp Neuropsychol, 2007, 29（7）：724-733.
［5］匡桂芳，傅平，周长虹，衡中玉. 抽动障碍患儿的智力记忆力自我意识及个性特征研究［J］. 中国行为医学科学，2004，13（5）:509-511.
［6］郑亚兵，宋雄. 泰必利和氟哌啶醇治疗多发性抽动症依从性比较［J］. 广西中医学院学报, 2002,15（2）:22-23.
［7］Pringsheim TA, Davenport WJ, Lang AC. Tics movement disorders［J］. Curr Opin Neurol, 2003, 16(4):523-527.
［8］Lichter DG, Jackson LA. Predictors of clonidine response in Tourette syndrome: implications and inferences［J］. J Child Neurol, 1996, 11(2):93-97.
［9］Gaffney GR, Perry PJ, Lund BC, Bever-Stille KA, Arndt S, Kuperman S. Risperidone versus clonidine in the treatment of children and adolescents with Tourette′s syndrome［J］. J Am Acad Child Adolesc Psychiatry, 2002, 41(3): 330-336.
［10］Singer HS, Gammon K, Quaskey S. Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment［J］. Pediatr Neurosci, 19851986, 12（2）:71-74.
［11］Behrman A, Goertemoeller S. A sticky situation: toxicity of clonidine and fentanyl transdermal patches in pediatrics［J］. J Emerg Nurs, 2007, 33(3):290-293.
